Sareum Holdings PLC

Sareum Holdings PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)87.50
  • Today's Change0.00 / 0.00%
  • Shares traded78.59k
  • 1 Year change-70.34%
  • Beta-0.7017
Data delayed at least 20 minutes, as of Dec 02 2022 16:29 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Friday, Sareum Holdings PLC (SAR:LSE) closed at 87.50, 15.51% above the 52 week low of 75.75 set on Nov 09, 2022.
52-week range
75.75Nov 09 2022345.00Apr 13 2022
Previous close87.50
Average volume80.93k
Shares outstanding68.07m
Free float63.73m
P/E (TTM)--
Market cap59.56m GBP
EPS (TTM)-0.0321
Data delayed at least 20 minutes, as of Dec 02 2022 16:29 GMT.
More ▼

Board of Directors


Stephen Parker, Non-Executive Chairman


Tim Mitchell, Founder and CEO


John Reader, Founder and CSO


Michael Owen, Non-Executive Director


Clive Birch, Non-Executive Director


Head Office:
Sareum Limited
Unit 2A, Langford Arch
London Road, Pampisford
CB22 3FX
United Kingdom

T: +44 (0) 1223 497700
F: +44 (0) 1223 497701
E: info@sareum.co.uk
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.